Departament of Obstetrics and Gynecology 2, University of Medicine Pharmacy Science and Technology George Emil Palade of Târgu Mureș, 540142 Târgu Mureș, Romania.
Departament of Neonatology, University of Medicine Pharmacy Science and Technology George Emil Palade of Târgu Mureș, 540142 Târgu Mureș, Romania.
Medicina (Kaunas). 2024 Sep 20;60(9):1544. doi: 10.3390/medicina60091544.
: The prevalence of overweight (OW), obesity (OB), and gestational diabetes mellitus (GDM) has been increasing worldwide in recent years. Adipolin is a new adipokine with reduced circulating levels in obesity and type 2 diabetes mellitus (T2DM). : Our prospective case-control study aimed to evaluate the maternal serum levels of adipolin and adiponectin, metabolic parameters, and anthropometric characteristics at the time of oral glucose tolerance test (OGTT) in pregnant women with a pre-pregnancy body mass index (BMI) ≥ 25 Kg/m and correlate them with newborn adipolin, adiponectin levels, and anthropometric characteristics of the newborns, and secondly to evaluate pregnancy outcomes. : After the OGTT results, we had 44 OW/OB pregnant women with GDM, 30 OW/OB pregnant women without GDM, and 92 lean healthy (LH) pregnant women. Data were analyzed by ANOVA and correlation tests, with a -value < 0.05 considered significant. : We found no differences between adipolin values of the OW/OB pregnant women with GDM and the LH group ( > 0.99), OW/OB without GDM and the LH group ( = 0.56), and between OW/OB groups ( = 0.57). OW/OB pregnant women with GDM had a higher rate of gestational hypertension compared with the LH group ( < 0.0001). Newborns from OW/OB pregnant women with GDM were more frequently diagnosed with jaundice ( = 0.02), and they required more frequent admission to the neonatal intensive care unit (NICU) for treatment of respiratory distress ( = 0.01) compared with newborns from LH mothers. : Our study revealed that the serum levels of adipolin in the second trimester among the group of OW/OB pregnant women with GDM, matched for age and BMI with OW/OB pregnant women without GDM, were not significantly different. This suggests that adipolin may not play an essential role in the occurrence of GDM in these patients. Despite good glycemic control during pregnancy, OW/OB pregnant women with GDM and their newborns tend to have more complications (gestational hypertension, jaundice, NICU admission) than LH pregnant women and their newborns, highlighting the importance of weight control before pregnancy.
: 近年来,超重(OW)、肥胖(OB)和妊娠期糖尿病(GDM)的患病率在全球范围内呈上升趋势。脂联素是一种新的脂肪因子,在肥胖症和 2 型糖尿病(T2DM)患者中循环水平降低。 : 我们的前瞻性病例对照研究旨在评估孕前体重指数(BMI)≥25kg/m 的孕妇在口服葡萄糖耐量试验(OGTT)时的血清脂联素和脂联素水平、代谢参数和人体测量特征,并将其与新生儿的脂联素、脂联素水平和新生儿的人体测量特征相关联,其次评估妊娠结局。 : OGTT 结果后,我们有 44 名患有 GDM 的 OW/OB 孕妇、30 名患有 GDM 的 OW/OB 孕妇和 92 名健康瘦(LH)孕妇。数据分析采用方差分析和相关检验,-值<0.05 认为有统计学意义。 : 我们发现,患有 GDM 的 OW/OB 孕妇和 LH 组之间的脂联素值没有差异(>0.99)、没有 GDM 的 OW/OB 孕妇和 LH 组之间的脂联素值也没有差异(=0.56),而且两组 OW/OB 孕妇之间的脂联素值也没有差异(=0.57)。患有 GDM 的 OW/OB 孕妇比 LH 组更易发生妊娠高血压(<0.0001)。患有 GDM 的 OW/OB 孕妇的新生儿更常被诊断为黄疸(=0.02),并且他们比 LH 母亲的新生儿更频繁地需要入住新生儿重症监护病房(NICU)接受呼吸窘迫治疗(=0.01)。 : 我们的研究表明,在患有 GDM 的 OW/OB 孕妇组中,在年龄和 BMI 与没有 GDM 的 OW/OB 孕妇相匹配的情况下,其血清脂联素水平在妊娠中期并没有显著差异。这表明脂联素可能在这些患者的 GDM 发生中没有起重要作用。尽管妊娠期血糖控制良好,但患有 GDM 的 OW/OB 孕妇及其新生儿比 LH 孕妇及其新生儿更容易出现并发症(妊娠高血压、黄疸、NICU 入院),这突出了孕前控制体重的重要性。